Hai–Ling Qiao
- Pharmacology top 0.5%
- Pharmacology top 5%
- Molecular Biology
- Oncology top 10%
- Epidemiology
- Topics
- Pharmacogenetics and Drug Metabolism (23 papers)Drug Transport and Resistance Mechanisms (13 papers)Liver Disease Diagnosis and Treatment (12 papers)
- Cited by
- PharmacologyBiochemistry
- Journals
- PLoS ONEOncogeneScientific Reports
- Partner nations
- ChinaUnited StatesNorway
In The Last Decade
Hai–Ling Qiao
66 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 93
- Pharmacology 478
- Pharmacology 342
- Molecular Biology 320
- Oncology 268
- Epidemiology 149
Countries citing papers authored by Hai–Ling Qiao
This map shows the geographic impact of Hai–Ling Qiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai–Ling Qiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai–Ling Qiao more than expected).
Fields of papers citing papers by Hai–Ling Qiao
This network shows the impact of papers produced by Hai–Ling Qiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai–Ling Qiao. The network helps show where Hai–Ling Qiao may publish in the future.
Co-authorship network of co-authors of Hai–Ling Qiao
This figure shows the co-authorship network connecting the top 25 collaborators of Hai–Ling Qiao. A scholar is included among the top collaborators of Hai–Ling Qiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hai–Ling Qiao. Hai–Ling Qiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 18 | |
| 4 | 10 | |
| 5 | 12 | |
| 6 | 11 | |
| 7 | 25 | |
| 8 | 8 | |
| 9 | 12 | |
| 10 | 10 | |
| 11 | 16 | |
| 12 | 35 | |
| 13 | 13 | |
| 14 | 9 | |
| 15 | 75 | |
| 16 | 85 | |
| 17 | 24 | |
| 18 | 15 | |
| 19 | 4 | |
| 20 | 41 |
About Hai–Ling Qiao
Hai–Ling Qiao is a scholar working on Pharmacology, Pharmacology and Biochemistry, having authored 71 papers that have together received 1.3k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (23 papers), Drug Transport and Resistance Mechanisms (13 papers) and Liver Disease Diagnosis and Treatment (12 papers). The work is most often cited by research in Pharmacology (478 citations), Pharmacology (342 citations) and Biochemistry (95 citations). Hai–Ling Qiao has collaborated with scholars based in China, United States and Norway. Frequent co-authors include Lin-Jing Jia, Yan Fang, Qiang Wen, Jie Gao, Xin Tian, Na Gao, J. Yang, Yi Zhang, Junbiao Chang and Haifeng Zhang. Their work appears in journals such as PLoS ONE, Oncogene and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.